SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?


To: Sergio H who wrote (20958)9/17/2000 5:55:05 PM
From: Ditchdigger  Respond to of 29382
 
Howdy Sergio,,I think I will withdraw AMD, using the -20% rule<g>..darn glad my stop kicked awhile back<g>
interesting headlines..http://news6.thdo.bbc.co.uk/hi/english/in_depth/world/2000/world_fuel_crisis/
"Opec defiant

Kuwait's Oil Minister Sheikh Saud Nasser Al-Sabah said on Friday that the volume of crude oil production was not to blame for high fuel prices in Europe.

Kuwait's Oil Minister Sheikh Saud Nasser Al-Sabah says fuel duty is to blame

"Taxes in Europe are too high.

"Consumers are convinced now that Opec is not responsible for the price hike, but taxes are.

"I hope they review tax rates in the interest of consumers," he said.
...
"The fresh price rises followed comments by Ali Rodriguez, who is also Venezuela's oil minister, who said on Monday: "We are approaching a crisis of great proportions because oil production capacity is reaching its limit".



To: Sergio H who wrote (20958)9/18/2000 12:58:41 AM
From: Ken W  Respond to of 29382
 
Sergio

" a surpise of volume and price prior to the news"

<GGGGGG> so much for the famous SEC FD rule.

Full disclosure is a joke for the simple fact that the market is dealing with human nature. Tell a secret to a dog if you want it to remain a secret, never to another human.

NUTX does have my interest

BTW: per the 20% rule lets dump SORC from the contest. The private placement of convertible debt caused the stock to sell off sharply combined with a .02 lower EPS over last year. Too bad too as SORC should have been able to grow just fine without convertible debt.

IMO these companies will never learn that convertibles are not the way to go, or there is just too much temptation to cut some sweet heart deals with friends at the expense of common share holders.

Ken



To: Sergio H who wrote (20958)9/18/2000 6:26:16 PM
From: Ken W  Read Replies (1) | Respond to of 29382
 
Sergio,

I'd like to replace SORC in the contest with ERICY at tomorrows open. Being the #2 player behind NOK can't be all bad and they seem to be the first coming to market with G3. biz.yahoo.com

Ken



To: Sergio H who wrote (20958)9/18/2000 8:30:50 PM
From: RCJIII  Read Replies (2) | Respond to of 29382
 
Amigos, check out BIPL. Profitable tiny genomics play with cash on the books, no debt and a clean balance sheet.

.07 in earnings in the last two quarters. (.02 and .05)

Sales rose 20% last quarter to $2,834,000.

Income rose 204% to $389,000.

8.3 million shares outstanding.

5.90 in the float.

They make diagnostic products to assess and diagnose various ailments and conditions.

They just closed a merger with Xtrana, a private company with technology used by genomics companies.

Their technology allows for extremely fast and reliable testing of RNA and DNA.

They just launched a new DNA test that they are very excited about.

They also should soon unveil a new very fast testing device for HIV.

Many other tests are in the works.

This is an interesting little company with great prospects. In genomics research, speed is everything and this company can help speed along several important tests.

The chart looks very compelling as well. In a very strong uptrend. Moved up nicely today in a very bad market.

I have been buying shares recently. I think it looks great.

RCJIII